Hazelden Betty Ford to open first clinic in Wisconsin
Hazelden Betty Ford, one of the nation's premier nonprofit providers of addiction treatment, is opening a clinic in Hudson 'to meet the growing needs of the community,' officials said.
The clinic, which will be located at 900 Crest View Drive, Suite 120, will have a 'mental health first' focus, and will offer 'expanded access to psychiatrists and therapists, as well as integrated care for co-occurring mental health and substance-use disorders,' officials said.
'So often substance-use and mental-health issues such as anxiety, depression and trauma go hand-in-hand,' said John Engebreth, executive director of Minnesota and Wisconsin outpatient service for Hazelden Betty Ford. 'We are opening this location to help residents of western Wisconsin manage these interrelated conditions – all in one place, close to home.'
A number of area foundations and local philanthropists provided financial support for the clinic, including the Fred C. and Katherine B. Andersen Foundation, Robert and Heidi Hubbard, the Hubbard Broadcasting Foundation, the Hugh J. Andersen Foundation, Ruth and John Huss, the Ben and Mary Whitney Fund and the William H. Phipps Foundation.
The clinic is slated to open April 7.
Health | Wisconsin appeals court overturns ruling allowing for emailing ballots to disabled voters
Health | St. Paul students cut the ribbon for the world's 200,000th Little Free Library
Health | Ontario premier backs down on US electricity hikes after speaking with Trump's commerce secretary
Health | Wisconsin boys state hockey: Late goals doom Amery in title game
Health | Hudson man charged with killing wife with knife in the couple's townhome
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
Kennedy to oust care task force, WSJ reports; HHS says no decision yet
By Ahmed Aboulenein and Deena Beasley WASHINGTON (Reuters) -U.S. Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover, the Wall Street Journal reported on Friday, citing people familiar with the matter. A Department of Health and Human Services spokesperson said on Friday that Kennedy had not yet made a decision regarding the 16-member U.S. Preventive Services Task Force. "No final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again," the HHS spokesperson said. The Journal said Kennedy planned to dismiss all 16 panel members in what would be the latest in a series of far-reaching actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. In June he fired all 17 members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, a panel of vaccine experts, replacing them with seven handpicked members, including known vaccine skeptics. The USPSTF includes medical experts serving staggered four-year terms on a volunteer basis. Its role in choosing what services will be covered by insurers was established under the 2010 Affordable Care Act, also known as Obamacare. The 40-year-old group, whose recommendations provide guidance to doctors, looks at everything from routine breast cancer screening to drugs to prevent HIV infection. The U.S. Supreme Court in June upheld the constitution of the task force and ruled in favor of its recommendation to cover preventive care. Though made up of an independent group of volunteer experts, members are selected by the health secretary without Senate confirmation and it relies on support from the department's Agency for Healthcare Research and Quality. A group of 104 health organizations, including the American Medical Association and the American Academy of Pediatrics, in early July sent a letter to Congressional health committees, urging them "to protect the integrity" of the task force. The task force has been criticized by some conservatives as too left-leaning.
Bloomberg
a day ago
- Bloomberg
FDA Investigates Death of Boy Who Got Sarepta's Gene Therapy
US regulators said they are investigating the death of an 8-year-old boy who received a gene therapy from Sarepta Therapeutics Inc. The death occurred on June 7, according to a statement from the US Food and Drug Administration.
Bloomberg
3 days ago
- Bloomberg
US Bans Mercury-Like Preservative From Flu Shots on Panel Advice
Health and Human Services Secretary Robert F. Kennedy Jr. ordered that thimerosal, a mercury-based preservative, be removed from US flu shots based on a recommendation from an influential vaccine panel. Kennedy formally adopted the June 26 recommendation of his revamped Advisory Committee on Immunization Practices, or ACIP. The decision impacts about 5% of flu shots given each season, according to data from the US Centers for Disease Control and Prevention.
